STOK Stoke Therapeutics, Inc.
Healthcare$31.03+5.76%ClosedMarket Cap: $1.93B
As of 2026-05-26
Analyst Consensus
Consensus
Buy
Target (Consensus)
$43.86
Target (Median)
$40.00
Target Range
$35.00 - $60.00
Upside from current price: 41.3%
Rating Distribution
1 Strong Buy11 Buy0 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-05-11 | BTIG | maintain | Buy | Buy |
| 2026-03-20 | Canaccord Genuity | maintain | Buy | Buy |
| 2026-03-19 | BTIG | maintain | Buy | Buy |
| 2026-03-18 | Wedbush | maintain | Outperform | Outperform |
| 2026-03-18 | Chardan Capital | maintain | Buy | Buy |
| 2026-03-17 | Needham | maintain | Buy | Buy |
| 2026-01-12 | Wedbush | maintain | Outperform | Outperform |
| 2026-01-05 | Canaccord Genuity | maintain | Buy | Buy |
| 2026-01-05 | Chardan Capital | maintain | Buy | Buy |
| 2025-12-15 | HC Wainwright & Co. | maintain | Buy | Buy |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Thu Dec 31 | $-3.38 | $27.2M | 9 |
| Fri Dec 31 | $-3.12 | $46.6M | 8 |
| Sun Dec 31 | $-2.07 | $124.1M | 7 |
| Mon Dec 31 | $-0.10 | $333.5M | 2 |